Mohit Bansal
Stock Analyst at Wells Fargo
(4.66)
# 801
Out of 4,361 analysts
741
Total ratings
58.7%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Rated: Buy | $165 | $131.10 | +25.86% | 60 | May 31, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $30 | $15.71 | +90.96% | 11 | May 31, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $145 | $115.17 | +25.90% | 50 | May 29, 2026 | |
| PFE Pfizer | Maintained: Hold | $28 | $25.63 | +9.25% | 48 | May 28, 2026 | |
| TVTX Travere Therapeutics | Rated: Buy | $40 → $50 | $45.04 | +11.01% | 19 | May 28, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,280 | $1,082.20 | +18.28% | 66 | May 27, 2026 | |
| BIIB Biogen | Maintained: Buy | $250 | $192.23 | +30.05% | 52 | May 22, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $54.95 | +9.19% | 41 | May 22, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $75 | $55.03 | +36.29% | 25 | May 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Rated: Hold | $825 → $700 | $600.66 | +16.54% | 65 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $68.14 | +10.07% | 25 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $265 | $232.64 | +13.91% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $140 | $91.70 | +52.68% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.46 | +44.51% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $550 | $438.40 | +25.46% | 47 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $375 → $390 | $329.13 | +18.49% | 47 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.26 | +107.67% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $31.11 | +76.79% | 15 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 | $212.93 | +22.11% | 38 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $175 | $161.00 | +8.70% | 31 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $8 | $1.36 | +488.24% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $33.94 | +106.25% | 7 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $53.41 | -12.00% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $75.20 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $14 | $19.79 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.00001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $1.20 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 → $75 | $19.05 | n/a | 3 | Mar 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $33 | $28.94 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.57 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $75 | $5.65 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5 | $0.0002 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $65 | $28.00 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $8.5 | $3.45 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $5 | $0.0063 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $9.19 | n/a | 1 | Jun 11, 2019 |
Gilead Sciences
May 31, 2026
Rated: Buy
Price Target: $165
Current: $131.10
Upside: +25.86%
Summit Therapeutics
May 31, 2026
Maintained: Buy
Price Target: $30
Current: $15.71
Upside: +90.96%
Merck & Co.
May 29, 2026
Maintained: Buy
Price Target: $145
Current: $115.17
Upside: +25.90%
Pfizer
May 28, 2026
Maintained: Hold
Price Target: $28
Current: $25.63
Upside: +9.25%
Travere Therapeutics
May 28, 2026
Rated: Buy
Price Target: $40 → $50
Current: $45.04
Upside: +11.01%
Eli Lilly and Company
May 27, 2026
Maintained: Buy
Price Target: $1,280
Current: $1,082.20
Upside: +18.28%
Biogen
May 22, 2026
Maintained: Buy
Price Target: $250
Current: $192.23
Upside: +30.05%
Bristol-Myers Squibb Company
May 22, 2026
Maintained: Hold
Price Target: $60
Current: $54.95
Upside: +9.19%
BioMarin Pharmaceutical
May 21, 2026
Rated: Buy
Price Target: $75
Current: $55.03
Upside: +36.29%
Regeneron Pharmaceuticals
May 18, 2026
Rated: Hold
Price Target: $825 → $700
Current: $600.66
Upside: +16.54%
May 13, 2026
Maintained: Hold
Price Target: $75
Current: $68.14
Upside: +10.07%
May 6, 2026
Maintained: Buy
Price Target: $250 → $265
Current: $232.64
Upside: +13.91%
May 6, 2026
Maintained: Buy
Price Target: $150 → $140
Current: $91.70
Upside: +52.68%
May 5, 2026
Maintained: Hold
Price Target: $5
Current: $3.46
Upside: +44.51%
May 5, 2026
Maintained: Buy
Price Target: $550
Current: $438.40
Upside: +25.46%
Apr 2, 2026
Rated: Hold
Price Target: $375 → $390
Current: $329.13
Upside: +18.49%
Apr 1, 2026
Maintained: Buy
Price Target: $13
Current: $6.26
Upside: +107.67%
Mar 13, 2026
Maintained: Buy
Price Target: $55
Current: $31.11
Upside: +76.79%
Mar 12, 2026
Rated: Buy
Price Target: $260
Current: $212.93
Upside: +22.11%
Feb 13, 2026
Maintained: Buy
Price Target: $180 → $175
Current: $161.00
Upside: +8.70%
Dec 16, 2025
Maintained: Buy
Price Target: $4 → $8
Current: $1.36
Upside: +488.24%
Nov 26, 2025
Maintained: Buy
Price Target: $70
Current: $33.94
Upside: +106.25%
Aug 12, 2025
Maintained: Buy
Price Target: $47
Current: $53.41
Upside: -12.00%
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $75.20
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $30 → $14
Current: $19.79
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.00001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $1.20
Upside: n/a
Mar 26, 2021
Initiated Coverage: Buy
Price Target: $15 → $75
Current: $19.05
Upside: n/a
Mar 24, 2021
Maintained: Buy
Price Target: $20 → $33
Current: $28.94
Upside: n/a
Feb 25, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.57
Upside: n/a
Jan 20, 2021
Maintained: Buy
Price Target: $36 → $75
Current: $5.65
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $10 → $5
Current: $0.0002
Upside: n/a
Dec 23, 2020
Maintained: Buy
Price Target: $75 → $65
Current: $28.00
Upside: n/a
Sep 15, 2020
Maintained: Hold
Price Target: $11 → $8.5
Current: $3.45
Upside: n/a
Apr 27, 2020
Maintained: Buy
Price Target: $8 → $5
Current: $0.0063
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $9.19
Upside: n/a